Erich W Baum

Title: Erich W. Baum - Innovator in Pharmaceutical Research

Introduction

Erich W. Baum, based in Durham, NC, is an accomplished inventor known for his significant contributions to the pharmaceutical industry. With one notable patent to his name, Baum has made strides in the field of medicinal chemistry, specifically focusing on innovative drug development.

Latest Patents

Baum's patent, titled "Imidazopyridine kinase inhibitors," presents a groundbreaking discovery that offers new imidazopyridine compounds and their compositions. This invention outlines processes for the preparation of these compounds and explores methods for their application as pharmaceutical agents, highlighting their potential in therapeutic arenas.

Career Highlights

Currently, Erich W. Baum is employed at GlaxoSmithKline LLC, a leading global healthcare company dedicated to improving the quality of human life through scientific innovation. His work at GSK underscores his commitment to advancing medical treatments and improving patient outcomes.

Collaborations

Baum collaborates closely with talented professionals, including colleagues Kevin Kuntz and David Edward Uehling. Working alongside these experts allows for a collaborative approach to research and development, enhancing the effectiveness and impact of their innovations.

Conclusion

Erich W. Baum stands out as a key figure in pharmaceutical innovation. With his patent on imidazopyridine kinase inhibitors, he is poised to contribute significantly to the field of medicine, offering new avenues for drug development that can positively affect countless lives.